Debbie Sue Gipson MD
Pediatric Chronic Renal Failure and Dialysis, Pediatric Glomerular Disease Nephrology
Professor of Pediatrics, Michigan Medicine, University of Michigan Medical School
Join to View Full Profile
1500 E Medical Center DrUniversity of MichiganAnn Arbor, MI 48109
Phone+1 734-936-4210
Dr. Gipson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pediatric Nephrology, 1995 - 1998
Indiana University School of MedicineResidency, Pediatrics, 1989 - 1993- Indiana University School of MedicineClass of 1989
University of WashingtonMS, Epidemiology
Certifications & Licensure
MI State Medical License 2009 - 2028
NC State Medical License 1999 - 2010
WA State Medical License 1993 - 1999
American Board of Pediatrics Pediatric Nephrology
Clinical Trials
- Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) Start of enrollment: 2005 Jul 01
- Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Start of enrollment: 2008 Dec 01
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
Publications & Presentations
PubMed
- Growth in children with nephrotic syndrome: a post hoc analysis of the NEPTUNE study.Aesha Maniar, Debbie S Gipson, Tammy Brady, Tarak Srivastava, David T Selewski
Pediatric Nephrology. 2024-09-01 - 1 citationsPediatric contributions and lessons learned from the NEPTUNE cohort study.Zubin J Modi, Yan Zhai, Jennifer Yee, Hailey Desmond, Wei Hao
Pediatric Nephrology. 2024-09-01 - 2 citationsLongitudinal analysis of blood pressure and lipids in childhood nephrotic syndrome.Johnathon Carboni, Elizabeth Thomas, Debbie S Gipson, Tammy M Brady, Tarak Srivastava
Pediatric Nephrology. 2024-07-01
Journal Articles
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGSHoward Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology
Authored Content
- US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United StatesFebruary 2018
Press Mentions
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseNovember 10th, 2018
Grant Support
- FSGS Cohort StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Multicenter Trial Of Focal GlomerulosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2009
- Clinical Trial: Mycophenolate Mofetil In Patients With 1ga NephropathyNational Center For Research Resources2008
- Clinical Trial: Gc1008 In Patients With Treatment Resistant Idiopathic FSGSNational Center For Research Resources2008
- Clinical Trial: Focal Segmental Glomerulosclerosis Clinical TrialNational Center For Research Resources2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
